Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05284721 · ClinicalTrials.gov registry record · NA
Family Peer Navigator for Early Psychosis for Black Families
A NA study of Family Members, sponsored by Washington State University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05284721: Recruiting NA study of Family Members, sponsored by Washington State University.
NCT05284721 is a NA study of Family Members that is actively recruiting participants, run by Washington State University. The registered enrollment target is 50 participants, below the 538-participant average among 11 other Family Members trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05284721, a NA study of Family Members, is actively recruiting participants, sponsored by Washington State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Building upon formative research, this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African American families.
Primary Outcome
Self-report measure to assess acceptability, a brief measure for family member participant. Items are scored from 1 to 4. Possible total scores range from 8 to 32, with higher scores (\>23) indicating greater satisfaction.
Conditions Studied
Interventions
- BEHAVIORAL Family Peer Navigator for Early Psychosis
- BEHAVIORAL Care Coordination
Study Locations (1)
Washington
- New Journeys: Coordinated Specialty care - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What NCT05284721 shows while recruiting
NCT05284721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 538-participant average among 11 other Family Members trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Family Members appearing as the primary indexed condition, and to 2 interventions - of which Family Peer Navigator for Early Psychosis is the first listed.
NCT05284721 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05284721 about?
NCT05284721 is a clinical study titled "Family Peer Navigator for Early Psychosis for Black Families". Building upon formative research, this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African Am...
What is the current status of trial NCT05284721?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-01-01. Estimated completion is 2025-09-30.
What conditions does trial NCT05284721 study?
This clinical trial studies the following conditions: Family Members.
What interventions are being tested in trial NCT05284721?
The interventions under investigation include: Family Peer Navigator for Early Psychosis (BEHAVIORAL), Care Coordination (BEHAVIORAL).
Who is sponsoring clinical trial NCT05284721?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05284721 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Family Members
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05284721's enrollment target sits among peer trials
50 10th of 11 higher than 2 of 11 other Family Members trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Family Members trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People At Risk for Alzheimer's Disease
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
RECRUITING · NA
-
FAmily Engagement Strategy for Coordinated Specialty Care
RECRUITING · NA
-
Using Structured Video Chat to Improve Relationships Between Young Children and Remote Grandparents
ACTIVE NOT RECRUITING · NA
-
Youth Nominated Support Team
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI